Medical/Pharmaceuticals
Evolve Beyond Limits: YIZUMI CONNECT 2026 Showcases
FOSHAN, China, May 20, 2026 /PRNewswire/ -- Following its presence at CHINAPLAS 2026 in Shanghai, YIZUMI brought its latest vision for advanced molding and smart manufacturing to YIZUMI CONNECT 2026 in Nanxun, forming a twin-city platform linking the two events. YIZUMI CONNECT 2026: Full-Process...
2026-05-20 21:00
6617
Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand
Building on a two-year scientific collaboration and co-authored peer-reviewed publication, the collaboration supports new approaches to herd health monitoring for New Zealand's dairy and beef sectors AUCKLAND, New Zealand, May 20, 2026 /PRNewswire/ -- Pictor, a global targeted proteomics platfor...
2026-05-20 20:56
3799
NCCN Affirms Commitment to Cancer-Related Distress Resources Worldwide During Mental Health Awareness Month
The latest version of the National Comprehensive Cancer Network's Distress Thermometer and Problem List is available for free in more than 70 languages. PLYMOUTH MEETING, Pa., May 20, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—an...
2026-05-20 20:03
5469
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centers CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-hu...
2026-05-20 20:00
6047
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
BEIJING, HANGZHOU, China and CAMBRIDGE, Mass., May 20, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a global leader in AI-powered drug delivery innovation, today announced that new preclinical data from its heart-targeted LNP program has been selected for a Late-Breaking oral presentation at the...
2026-05-20 18:57
6804
Celebrate National Physical Fitness & Sports Month: Breathe Better, Move Freely with Oxygen Support
NEW YORK, May 20, 2026 /PRNewswire/ -- May is National Physical Fitness &
Sports Month, a time to celebrate staying active and prioritizing health at
every stage of life.VARON
2026-05-20 14:32
6176
Hyundai Bioscience: "Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread"
SEOUL, South Korea, May 20, 2026 /PRNewswire/ -- Hyundai Bioscience announced on May 19th that it can supply clinical trial doses of its broad-spectrum antiviral drug XAFTY® in response to growing global concern over infectious disease outbreaks caused by Ebola and hantavirus. Hyundai Bioscien...
2026-05-20 13:57
6671
WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization
TOKYO, May 20, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), recently hosted its third CRDMO Day in Tokyo, bringing together senior leaders and experts from Japan's biopharmaceutical industry, exchanging the ...
2026-05-20 13:44
9076
Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility
QINGDAO, China, May 20, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medical solutions, has released its 2025 Sustainability Report, providing a comprehensive overview of the company's measurable progress achieved in environmental, social, and governance...
2026-05-20 12:23
7656
Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research
Collaboration expands research of new delivery platform beyond liver tissues
supporting potential preclinical development and strengthens Singapore's
position as a biomedical innovation hub
SINGAPORE, May 20, 2026 /PRNewswire/ -- Agilent Technologies Inc.
2026-05-20 11:00
6337
ATxSummit 2026 Opens with Shared Regional Ambition to Harness AI for Public Good
SINGAPORE, May 20, 2026 /PRNewswire/ -- ATxSummit 2026, hosted by the Infocomm Media Development Authority of Singapore, officially kicked off this evening with Singapore President Tharman Shanmugaratnam as the Guest-of-Honour at the Opening Gala Dinner at Gardens by the Bay. This year's ATxSummi...
2026-05-20 08:43
6553
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
SHANGHAI and HONG KONG, May 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...
2026-05-20 08:00
6554
PRC-Saltillo Named to Forbes Accessibility 200 List
WOOSTER, Ohio, May 20, 2026 /PRNewswire/ -- PRC-Saltillo has been named to the
2026 Forbes Accessibility 200 list
2026-05-20 01:38
8241
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening HOUSTON, May 19, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free ...
2026-05-19 23:45
9172
PartnerOne Launches a Global Philanthropic Initiative to Expand Pediatric Surgical Care in Developing Countries
PartnerOne Global Surgery (POGS) begins with a $10 million commitment from PartnerOne and an inaugural partnership with Montreal Children's Hospital, one of the most renowned pediatric hospitals in the world. RIVERSIDE, Calif., May 19, 2026 /PRNewswire/ -- PartnerOne announced the launch of Part...
2026-05-19 21:00
7568
ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA
SINGAPORE, May 19, 2026 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the
"Company") (OTC: ALRTF), the diabetes management company, announces the
GluCurve Pet CGM ("GluCurve") is now for sale in Canada at www.GluCurve.ca
2026-05-19 20:28
4541
Fujitsu, SMBC Group and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare
Companies aim to extend healthy life expectancy, optimize management of healthcare institutions, and curb national healthcare costs Sumitomo Mitsui Financial Group, Inc. Fujitsu Limited SoftBank Corp. TOKYO, May 19, 2026 /PRNewswire/ -- Fujitsu Limited (Fujitsu), Sumitomo Mitsui Financial Group,...
2026-05-19 14:28
9100
BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology
Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology BERLIN, May 19, 2026 /PRNewswire/ -- BIOTRONIK, die Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation today announced a research and innovation partnership focused on advancing digital and tr...
2026-05-19 14:00
4142
Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic Effects
CBL-514, when combined separately with two leading GLP-1R-based weight-loss therapies, semaglutide and tirzepatide, demonstrated enhanced weight loss, attenuated post-discontinuation weight regain, and greater reductions in subcutaneous and visceral fat in animal studies. The presentation also ma...
2026-05-19 13:19
8331
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC
NANJING, China, May 18, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), has received approval from the Center for Drug Evaluation (CDE) of Chi...
2026-05-19 09:35
7238
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Nuix Neo Generative AI Framework
[Picked up by 262 media titles]
2026-10-08 08:02Ampotech and Buskowitz Energy Collaborate to Deliver Integrated Energy Solutions Combining Energy Efficiency, Solar and Battery Storage
[Picked up by 261 media titles]
2026-10-14 09:30
Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
13586
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
11416
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
11031
